GLP-1 Drugs Cut Obesity-Linked Cancer Risk by 41%, Surpassing Surgery
New research reveals that popular weight-loss drugs might do more than help people shed pounds – they could reduce the risk of obesity-related cancers by 41%. A breakthrough study of 6,000 adults